Capital One Financial Corporation to Webcast Conference Call on Second Quarter 2025 Earnings
MCLEAN, Va.--(BUSINESS WIRE)--On Tuesday, July 22, 2025, at approximately 4:05 p.m. Eastern Time, Capital One Financial Corporation (NYSE: COF) will release its second quarter 2025 earnings results. Additionally, the company will host a conference call at 5:00 p.m. Eastern Time to review financial and operating performance for the quarter ending June 30, 2025.
The call will be webcast live and the earnings release will be available on the company's homepage at www.capitalone.com. A replay of the webcast will be available 24 hours a day, beginning two hours after the conference call, until 5:00 p.m. Eastern Time on August 5, 2025, through the company's homepage.
About Capital One
Capital One Financial Corporation (www.capitalone.com) is a financial holding company which, along with its subsidiaries, had $367.5 billion in deposits and $493.6 billion in total assets as of March 31, 2025. Headquartered in McLean, Virginia, Capital One offers a broad spectrum of financial products and services to consumers, small businesses and commercial clients through a variety of channels. Capital One, N.A. has branches and Cafés located primarily in New York, Louisiana, Texas, Maryland, Virginia and the District of Columbia. A Fortune 500 company, Capital One trades on the New York Stock Exchange under the symbol 'COF' and is included in the S&P 100 index.
Additional information about Capital One can be found at Capital One About, or on LinkedIn at linkedin.com/company/capital-one/.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Retail Traders Just Sent This AI Health Stock Soaring 60%
Oscar Health (NYSE:OSCR) has exploded nearly 60% this week, adding close to $2 billion in market cap without a single press release or earnings update. The real catalyst? A retail trading frenzy. OSCR became one of the most-mentioned names on r/WallStreetBets, and trading volume followed suitnearly 50 million shares changed hands on Wednesday alone, the second-highest in the company's history. Options activity lit up as well, with call volumes hitting a record 152,414 that day, and another 95,000 contracts moving by Friday morning, nearly triple the norm. Beneath the surge is a company with serious revenue momentumup 48% in 2023 and 57% in 2024. Adjusted earnings per share reached $0.92 in Q1 2025. But Oscar isn't just selling insuranceit's selling a story. Management brands the company as a health-tech platform, powered by AI and run on what it calls a continuous hackathon model. That pitch, familiar to anyone who's followed high-multiple tech names, is likely helping Oscar catch a more generous valuation than traditional insurers. Retail traders appear to be buying into that promise. Another factor? The Kushner connection. Joshua Kushner, vice chairman of Oscar's board and brother to Jared Kushner, has remained a prominent name in business and politics alike. That visibility might be adding an extra layer of speculation to the mix. But for now, the stock's movement is being driven more by momentum than fundamentals. Oscar is just $3 shy of its all-time highand the retail crowd seems determined to carry it the rest of the way. This article first appeared on GuruFocus.
Yahoo
an hour ago
- Yahoo
S&P 500 Gains and Losses Today: Kroger Stock Soars, Accenture Shares Drop
The S&P 500 slid 0.2% on Friday, June 20, wrapping up the shortened trading week as investors mulled the implications of the ongoing conflict in the Middle East. Accenture reported lower-than-expected quarterly bookings, and its shares tumbled. Kroger shares surged after the grocery store operator topped profit and identical sales U.S. equities indexes were mixed on the day after the Juneteenth holiday, wrapping up the shortened trading week. The fighting between Israel and Iran remained in focus as President Donald Trump pointed to a two-week time frame for a decision on potential U.S. involvement in the conflict. The S&P 500 slipped 0.2%, closing in negative territory for the third straight session. The Nasdaq was down 0.5%, but the Dow eked out a gain of 0.1%. Accenture (ACN) shares tumbled 6.9%, falling the furthest of any S&P 500 stock, after the professional services firm's bookings for its fiscal third quarter fell shy of analysts' expectations. Although sales and profits for the quarter topped forecasts, boosted by demand related to artificial intelligence (AI) services, Accenture's CEO noted that companies are holding off on hiring consultants in response to the uncertain global economic backdrop. Shares of Albemarle (ALB), the world's largest lithium miner, dropped 4.6% after analysts at UBS reaffirmed their cautious stance on the lithium market. The firm pointed to ongoing oversupply and pricing pressure for the key battery component, suggesting that joint venture structures and strong balance sheets have contributed to making lithium producers slow to make supply adjustments in response to the weak pricing environment. Steel Dynamics (STLD) shares slipped 3.2%, extending losses posted this week after the steelmaker issued lower-than-expected profit guidance for the current quarter. Friday's downtick came after Keybanc analysts trimmed their price target on the stock, citing expected softness in galvanized steel spreads. Kroger (KR) shares surged 9.8%, notching the top performance in the S&P 500 on Friday. The operator of the largest chain of traditional grocery stores in the U.S. posted better-than-expected profit and identical sales growth for its fiscal first quarter. While Kroger's chief financial officer discussed ongoing macroeconomic uncertainty, the company boosted its full-year identical sales growth forecast and maintained its other guidance. The food retailer did not provide an update on its search for a new CEO following the resignation of its previous leader in March amid a probe into alleged misconduct. Shares of residential construction materials supplier Builders FirstSource (BLDR) jumped 7.5%. Although Wedbush analysts trimmed their price target on the stock, citing the potential for soft-oriented strand board pricing to weigh on Builders FirstSource's second-quarter results, they maintained their "outperform" rating, suggesting that sales trends could be priced in at current levels following the stock's year-to-date decline. Used-car seller CarMax (KMX) topped quarterly profit estimates, and its shares rose 6.6%. Although sales came in slightly below expectations, total revenue was up 6% from the year-ago period, boosted by a 9% year-over-year gain in retail vehicle sales. Read the original article on Investopedia Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders' Equity Requirements
NYSE American previously issued similar warning for same matter and issued the new notice because the deficiency remains as of March 31, 2025 AIM has until June 11, 2026 to regain compliance OCALA, Fla., June 20, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. ('AIM' or the 'Company') (NYSE American: AIM) today announced the receipt of a warning notification (the 'Letter') from the NYSE American LLC (the 'NYSE American') stating that the Company is not in compliance with the minimum stockholders' equity requirements of Sections 1003(a)(ii) and 1003(a)(iii) of the NYSE American Company Guide (the 'Company Guide') requiring stockholders' equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years and $6.0 million or more if the Company has reported losses from continuing operations and/or net losses in its five most recent fiscal years, respectively. As of March 31, 2025, the Company had a stockholders' deficit of negative $3.9 million and has had losses in the most recent five fiscal years ended December 31, 2024. The NYSE American previously issued a warning on December 17, 2024 for the same reasons and has issued the Letter because the deficiency remains as of March 31, 2025, when the Company filed its quarterly report on Form 10-Q for the first quarter of fiscal 2025. On February 26, 2025, the NYSE American accepted a plan submitted by the Company to regain compliance by June 11, 2026. Accordingly, the Company still has until June 11, 2026 to regain compliance. The Company's common stock recommenced trading on the NYSE American on June 17, 2025 under the symbol 'AIM'. The Letter in no way has any effect on such trading and does not affect the Company's business, operations or reporting requirements with the U.S. Securities and Exchange Commission. About AIM ImmunoTech Inc. AIM ImmunoTech Inc. is an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company's lead product is a first-in-class investigational drug called Ampligen® (rintatolimod), a dsRNA and highly selective TLR3 agonist immuno-modulator with broad spectrum activity in clinical trials for globally important cancers, viral diseases and disorders of the immune system. For more information, please visit and connect with the Company on X, LinkedIn, and Facebook. Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including, but not limited to, statements that are based upon management's current expectations, assumptions, estimates, projections and beliefs. The use of words such as, but not limited to, 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'might,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' or 'would' and similar words or expressions are intended to identify forward-looking statements. These statements include, but are not limited to, statements regarding the Company's intention to regain compliance with the listing requirements of the NYSE American and its ability to do so. These statements involve risks, uncertainties and other factors that may cause actual results or achievements to be materially different and adverse from those expressed in or implied by the forward-looking statements. The Company urges investors to consider specifically the various risk factors identified in its most recent Form 10-K, and any risk factors or cautionary statements included in any subsequent Form 10-Q or Form 8-K, filed with the U.S. Securities and Exchange Commission. The forward-looking statements contained herein speak only as of the date hereof, and the Company assumes no obligation to update any forward-looking statements, whether as a result of new information, subsequent events or otherwise, except as required by law. CONTACT: Investor Contact: JTC Team, LLC Jenene Thomas 908.824.0775 AIM@ in to access your portfolio
